News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995


3/13/2014 7:33:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

British allergy treatment firm Circassia priced its initial public share offer at the top of its price range on Thursday, in the biggest biotech debut on the London market for years. The listing at 310 pence per share values the company at about 581 million pounds ($965 million), making it the largest biotech IPO since at least 1995, according to life science publication EP Vantage. The last major IPO in the sector was Ark Therapeutics which raised 55 million pounds ($91.3 million) in London in 2004.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Bloomberg
Read at Financial Times
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES